Its a really challenging conversation for each of us
Following the patent expiry of Ozempic, Wegovy, and Rybelsus on March 20, 2026, generic Semaglutide is now available in India, China, Canada, Brazil, and a few other countries
Retatrutides profile largely mirrors other incretin-based therapies, with some notable distinctions related to its triple mechanism
This discovery led to the development of exenatide, which in 2005 became the first GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes (T2DM)
These arent regulated by the GLP-1 medications are likely to be more effective than dietary supplements, but these medications are only prescribed for certain conditions, such as diabetes and obesity
Shortly after, the new pill will be broadly available through brick and mortar pharmacies and telehealth providers